Previously, Richter et al (2016)31 documented that TNF inhibitors are linked to a higher risk of severe infections in the early stages of treatment, but as they become much more effective, the risk reduces due to improved functional ability and reduced glucocorticoids usage. Here, TNF is linked to infection.